More on LeMaitre Vascular's Q2 results (NASDAQ:LMAT)
LeMaitre Vascular's (LMAT 12.8%) Q2 sales declined 16% Y|Y to $24.9M with sales in the Americas (-15%) and Europe|Middle East|Africa (-21%) due to COVID-1
More on LeMaitre Vascular's Q2 results (NASDAQ:LMAT)
LeMaitre Vascular's (LMAT 12.8%) Q2 sales declined 16% Y|Y to $24.9M with sales in the Americas (-15%) and Europe|Middle East|Africa (-21%) due to COVID-1